Les Meilleurs Médecins au Monde

Le Dr Sangkyu Park est un neurochirurgien expérimenté qui possède plus de 18 ans d'expérience dans ce domaine. Il est spécialisé dans les maladies cérébrovasculaires, les anévrismes cérébraux et d'autres affections connexes. Il est diplômé en 2003 de la faculté de médecine de l'université de Hanyang, titulaire d'une maîtrise et d'un doctorat de la Graduate School of Medicine, et membre de diverses sociétés médicales. Il est l'auteur de chapitres de livres et a été publié dans plusieurs revues nationales et internationales.

Dr. Aleix Prat is a clinical scientist with expertise in breast cancer research, gene expression, and clinical trials. He earned his MD from the University of Barcelona. He completed his oncology fellowship at Vall d’Hebron Institute of Oncology. Dr. Prat leads the Translational Genomics and Targeted Therapeutics in Solid Tumors Group at IDIBAPS. He is also President of SOLTI and serves on the Executive Committee of The Breast International Group.

Dr. Prat has published over 160 scientific papers. His work has received 13,479 citations, and he has an H-Index of 51. He is a Tenure-Track Professor at the University of Barcelona. He also directs the Breast Pathology–Senology Master’s degree. His roles highlight his strong academic and clinical contributions to oncology.

Dr. Ana Oaknin is a Medical Oncologist with expertise in angiogenesis, DNA repair, and immunology. She focuses on gynecological cancers. Dr. Oaknin earned her medical degree and MD in Medical Oncology from Complutense University of Madrid. She also holds a PhD from Universidad Autonoma de Barcelona.

Dr. Oaknin is Co-Chair of the GEICO Group. She is a faculty member for the Gyn-Track in the European Society of Medical Oncology. She represents Spain in the GOG and GCIG committees. Dr. Oaknin is an active member of ASCO, ESMO, and SEOM. She has published over 100 scientific articles and presentations. She also leads several clinical trials in ovarian, cervical, and endometrial cancer.

Dr. Francesc Bosch is an expert in Chronic Lymphocytic Leukemia (CLL) and lymphomas. He leads research in the molecular causes and new treatments for CLL and other lymphoproliferative disorders.

He has published over 100 articles in leading journals, including The New England Journal of Medicine and Nature Medicine. Dr. Bosch oversees more than 80 clinical studies, from phase 1 to phase 3, and plays a key role in developing new drugs.

He is the Head of Hematology at Vall d’Hebron University Hospital and IOB Institute of Oncology. He also serves as president of GELLC and is a professor of hematology. His work has improved diagnosis and treatment for blood diseases.

Neurochirurgien de la colonne vertébrale

Oncogynécologue, spécialiste des opérations laparoscopiques

Neurologue

Professeur spécialisé dans les chirurgies laparoscopiques de l'intestin, le traitement du cancer du rectum et du colon et les opérations mini-invasives de l'anus, avec 15 ans d'expérience. Membre de la Société internationale des chirurgiens universitaires du côlon et du rectum, de la Société américaine des chirurgiens abdominaux, de l'Association américaine de chirurgie et de la Société européenne de coloproctologie.

Oncologiste

Oncologiste

Oncologiste

Oncologiste

Oncologiste

Oncologiste

Oncologiste

Oncologiste

Oncologue. Spécialiste du traitement du cancer du sein